{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:59:04Z","timestamp":1776347944259,"version":"3.51.2"},"reference-count":137,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Epithelial ovarian cancer (EOC) is the18th most common cancer worldwide and the 8th most common in women. The aim of this study was to diagnose the potential importance of, as well as novel genes linked with, EOC and to provide valid biological information for further research. The gene expression profiles of E-MTAB-3706 which contained four high-grade ovarian epithelial cancer samples, four normal fallopian tube samples and four normal ovarian epithelium samples were downloaded from the ArrayExpress database. Pathway enrichment and Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) were performed, and protein-protein interaction (PPI) network, microRNA-target gene regulatory network and TFs (transcription factors) -target gene regulatory network for up- and down-regulated were analyzed using Cytoscape. In total, 552 DEGs were found, including 276 up-regulated and 276 down-regulated DEGs. Pathway enrichment analysis demonstrated that most DEGs were significantly enriched in chemical carcinogenesis, urea cycle, cell adhesion molecules and creatine biosynthesis. GO enrichment analysis showed that most DEGs were significantly enriched in translation, nucleosome, extracellular matrix organization and extracellular matrix. From protein-protein interaction network (PPI) analysis, modules, microRNA-target gene regulatory network and TFs-target gene regulatory network for up- and down-regulated, and the top hub genes such as E2F4, SRPK2, A2M, CDH1, MAP1LC3A, UCHL1, HLA-C (major histocompatibility complex, class I, C), VAT1, ECM1 and SNRPN (small nuclear ribonucleoprotein polypeptide N) were associated in pathogenesis of EOC. The high expression levels of the hub genes such as CEBPD (CCAAT enhancer binding protein delta) and MID2 in stages 3 and 4 were validated in the TCGA (The Cancer Genome Atlas) database. CEBPD andMID2 were associated with the worst overall survival rates in EOC. In conclusion, the current study diagnosed DEGs between normal and EOC samples, which could improve our understanding of the molecular mechanisms in the progression of EOC. These new key biomarkers might be used as therapeutic targets for EOC.<\/jats:p>","DOI":"10.3390\/diagnostics9020039","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T03:47:36Z","timestamp":1554868056000},"page":"39","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics"],"prefix":"10.3390","volume":"9","author":[{"given":"Varun Chandra","family":"Alur","sequence":"first","affiliation":[{"name":"Department of Endocrinology, J.J. M Medical College, Davanagere, Karnataka 577004, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varshita","family":"Raju","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, J.J. M Medical College, Davanagere, Karnataka 577004, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basavaraj","family":"Vastrad","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SET\u2019S College of Pharmacy, Dharwad, Karnataka 580002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-4450","authenticated-orcid":false,"given":"Chanabasayya","family":"Vastrad","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad, Karanataka 580001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"ref_1","first-page":"4722","article-title":"Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas","volume":"62","author":"Schwartz","year":"2002","journal-title":"Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0889-8588(18)30311-3","article-title":"Oncogenes in ovarian cancer","volume":"6","author":"Berchuck","year":"1992","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_5","first-page":"567","article-title":"Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review)","volume":"16","author":"Aunoble","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00432-014-1765-5","article-title":"Oncogenes associated with drug resistance in ovarian cancer","volume":"141","author":"Liu","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.3390\/ijms130911705","article-title":"Mechanisms of ovarian cancer metastasis: Biochemical pathways","volume":"13","author":"Nakayama","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5732\/cjc.014.10289","article-title":"The PI3K\/Akt\/mTOR pathway in ovarian cancer: Therapeutic opportunities and challenges","volume":"34","author":"Cheaib","year":"2015","journal-title":"Chin. J. Cancer."},{"key":"ref_9","first-page":"960327","article-title":"MET\/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction","volume":"2012","author":"Afkhami","year":"2012","journal-title":"Patholog. Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.0801615105","article-title":"Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1541-7786.MCR-05-0138","article-title":"Frequent IGF2\/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer","volume":"4","author":"Murphy","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/93.19.1458","article-title":"Prostasin, a potential serum marker for ovarian cancer: Identification through microarray technology","volume":"93","author":"Mok","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/hmg\/10.7.657","article-title":"Tissue microarray technology for high-throughput molecular profiling of cancer","volume":"10","author":"Kallioniemi","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/bioinformatics\/btm311","article-title":"Beadarray: R classes and methods for Illumina bead-based data","volume":"23","author":"Dunning","year":"2007","journal-title":"Bioinformatics."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"Lumi: A pipeline for processing Illumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkq418","article-title":"ToppCluster: A multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems","volume":"38","author":"Kaimal","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471250953.bi0112s11","article-title":"Using the KEGG database resource","volume":"11","author":"Aoki","year":"2005","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"D471","DOI":"10.1093\/nar\/gkv1164","article-title":"The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway\/genome databases","volume":"44","author":"Caspi","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"D674","DOI":"10.1093\/nar\/gkn653","article-title":"PID: The Pathway Interaction Database","volume":"37","author":"Schaefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1002\/pmic.201100066","article-title":"Reactome pathway analysis to enrich biological discovery in proteomics data sets","volume":"11","author":"Haw","year":"2011","journal-title":"Proteomics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng0502-19","article-title":"GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways","volume":"31","author":"Dahlquist","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gks1118","article-title":"PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees","volume":"41","author":"Mi","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2041-1480-5-7","article-title":"The pathway ontology-updates and applications","volume":"5","author":"Petri","year":"2014","journal-title":"J. Biomed. Semant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"D478","DOI":"10.1093\/nar\/gkt1067","article-title":"SMPDB 2.0: Big improvements to the Small Molecule Pathway Database","volume":"42","author":"Jewison","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","article-title":"InnateDB: Systems biology of innate immunity and beyond--recent updates and continuing curation","volume":"41","author":"Breuer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"D358","DOI":"10.1093\/nar\/gkt1115","article-title":"The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases","volume":"42","author":"Orchard","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"D449","DOI":"10.1093\/nar\/gkh086","article-title":"The Database of Interacting Proteins: 2004 update","volume":"32","author":"Salwinski","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"D857","DOI":"10.1093\/nar\/gkr930","article-title":"MINT, the molecular interaction database: 2012 update","volume":"40","author":"Licata","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/nar\/gkg056","article-title":"BIND: The Biomolecular Interaction Network Database","volume":"31","author":"Bader","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"Oughtred","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zaki, N., Efimov, D., and Berengueres, J. (2013). Protein complex detection using interaction reliability assessment and weighted clustering coefficient. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-163"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1261\/rna.2239606","article-title":"TarBase: A comprehensive database of experimentally supported animal microRNA targets","volume":"12","author":"Sethupathy","year":"2006","journal-title":"RNA."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"miRTarBase update 2018: A resource for experimentally validated microRNA-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nprot.2015.052","article-title":"NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data","volume":"10","author":"Xia","year":"2015","journal-title":"Nat. Protoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","article-title":"ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments","volume":"26","author":"Lachmann","year":"2010","journal-title":"Bioinformatics."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1109\/TCBB.2014.2361350","article-title":"A Topology Potential-Based Method for Identifying Essential Proteins from PPI Networks","volume":"12","author":"Li","year":"2015","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.1038\/srep16830","article-title":"Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma","volume":"5","author":"Azevedo","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-0381-4-10","article-title":"Using graph theory to analyze biological networks","volume":"4","author":"Pavlopoulos","year":"2011","journal-title":"BioData Min."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"i277","DOI":"10.1093\/bioinformatics\/btn182","article-title":"Identifying gene-disease associations using centrality on a literature mined gene-interaction network","volume":"24","author":"Vu","year":"2008","journal-title":"Bioinformatics"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hao, D., Ren, C., and Li, C. (2012). Revisiting the variation of clustering coefficient of biological networks suggests new modular structure. BMC Syst. Biol., 6.","DOI":"10.1186\/1752-0509-6-34"},{"key":"ref_46","first-page":"2735","article-title":"MicroRNAs and cancer: Key paradigms in molecular therapy","volume":"15","author":"Tan","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_47","first-page":"1532","article-title":"Use of transcription factors as agents and targets for drug development","volume":"10","author":"Smith","year":"1996","journal-title":"Oncology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4757-3587-1_3","article-title":"Early detection of ovarian cancer: Promise and reality","volume":"Volume 107","author":"Bast","year":"2002","journal-title":"Ovarian Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.onc.1203598","article-title":"Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer","volume":"19","author":"Yuan","year":"2000","journal-title":"Oncogene."},{"key":"ref_50","first-page":"5382","article-title":"An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer","volume":"60","author":"Suzuki","year":"2000","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ijc.24546","article-title":"Epigenetic silencing of argininosuccinatesynthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer","volume":"125","author":"Nicholson","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1073\/pnas.1037154100","article-title":"Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells","volume":"100","author":"Devoogdt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cancergencyto.2004.11.011","article-title":"In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer","volume":"160","author":"Israeli","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22936","DOI":"10.1074\/jbc.273.36.22936","article-title":"Heparan sulfate oligosaccharides require 6-O-sulphation for promotion of basic fibroblast growth factor mitogenic activity","volume":"273","author":"Pye","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3892\/mco.2013.151","article-title":"Overexpression of heparan sulfate 6-O-sulfotransferase-2 in colorectal cancer","volume":"1","author":"Hatabe","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/sj.bjc.6603747","article-title":"Heparansulphate synthetic and editing enzymes in ovarian cancer","volume":"96","author":"Backen","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1205171","article-title":"Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells","volume":"21","author":"Moll","year":"2002","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<654::AID-IJC26>3.0.CO;2-7","article-title":"Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin","volume":"75","author":"Hayashido","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0002-9440(10)65746-X","article-title":"Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors","volume":"53","author":"Roger","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"40524","DOI":"10.1038\/srep40524","article-title":"Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1158\/0008-5472.CAN-04-3877","article-title":"The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation","volume":"65","author":"Frede","year":"2005","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Xiang, T., Li, L., Yin, X., Yuan, C., Tan, C., Su, X., Xiong, L., Putti, T.C., Oberst, M., and Kelly, K. (2012). The ubiquitin peptidase UCHL1 induces G0\/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029783"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7150\/jca.6641","article-title":"UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance","volume":"4","author":"Jin","year":"2013","journal-title":"J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ijc.22025","article-title":"Silencing of the UCHL1 gene in human colorectal and ovarian cancers","volume":"119","author":"Nakazawa","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ijc.29502","article-title":"Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells","volume":"137","author":"Horak","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.0022-202X.2004.22322.x","article-title":"Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers","volume":"122","author":"Suomela","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jss.2014.06.055","article-title":"Interferon alpha-inducible protein 27 promotes epithelial-mesenchymal transition and induces ovarian tumorigenicity and stemness","volume":"193","author":"Li","year":"2015","journal-title":"J. Surg. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijc.23913","article-title":"Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin","volume":"124","author":"Lee","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cncr.23989","article-title":"Promoter methylation of the Wnt\/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer","volume":"115","author":"Yu","year":"2009","journal-title":"Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00432-010-0916-6","article-title":"Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer","volume":"137","author":"You","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/carcin\/22.1.67","article-title":"Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: Risk of ovarian cancer by histological subtype","volume":"22","author":"Spurdle","year":"2001","journal-title":"Carcinogenesis"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1155\/2012\/497692","article-title":"Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk","volume":"33","author":"Oliveira","year":"2012","journal-title":"Dis. Mark."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1054\/bjoc.2001.1907","article-title":"Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer","volume":"85","author":"McFadyen","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1098-2744(199611)17:3<160::AID-MC8>3.0.CO;2-J","article-title":"Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer","volume":"17","author":"Lancaster","year":"1996","journal-title":"Mol. Carcinog."},{"key":"ref_75","first-page":"107","article-title":"Genetic alterations in chromosome 10q24.3 and glutathione S-transferase omega 2 gene polymorphism in ovarian cancer","volume":"25","author":"Pongstaporn","year":"2006","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2012.05.029","article-title":"MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival","volume":"126","author":"Hetland","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/pros.10192","article-title":"Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism","volume":"54","author":"Ji","year":"2003","journal-title":"Prostate"},{"key":"ref_78","first-page":"309","article-title":"Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: A retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens","volume":"9","author":"Kollander","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/1078-0432.1226.11.3","article-title":"UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine\/irinotecan","volume":"11","author":"Carlini","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djs126","article-title":"CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients","volume":"104","author":"Rae","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature22359","article-title":"CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells","volume":"546","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1089\/scd.2014.0588","article-title":"VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients","volume":"24","author":"Kwon","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mc.21966","article-title":"G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer","volume":"53","author":"Li","year":"2014","journal-title":"Mol. Carcinog."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Lim, W., Kim, H.S., Jeong, W., Ahn, S.E., Kim, J., Kim, Y.B., Kim, M.A., Kim, M.K., Chung, H.H., and Song, Y.S. (2012). SERPINB3 in the chicken model of ovarian cancer: A prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049869"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1349-7006.2012.02224.x","article-title":"Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers","volume":"103","author":"Toyama","year":"2012","journal-title":"Cancer Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1440-1827.2007.02168.x","article-title":"High-level expression of CD109 is frequently detected in lung squamous cell carcinomas","volume":"57","author":"Sato","year":"2007","journal-title":"Pathol. Int."},{"key":"ref_87","first-page":"35","article-title":"Methylation of the 5\u2019 CpG island of the endothelin B receptor gene is common in human prostate cancer","volume":"57","author":"Nelson","year":"1997","journal-title":"Cancer Res."},{"key":"ref_88","first-page":"379568","article-title":"The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas","volume":"2015","author":"Liang","year":"2015","journal-title":"Dis. Mark."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12094-015-1348-1","article-title":"Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma","volume":"18","author":"Karabulut","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1476-4598-12-60","article-title":"Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers","volume":"12","author":"Oshima","year":"2013","journal-title":"Mol. Cancer."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10555-009-9182-y","article-title":"The biological role and regulation of versican levels in cancer","volume":"28","author":"Ricciardelli","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.11423","article-title":"Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis","volume":"107","author":"Voutilainen","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.LAB.0000043124.75633.ED","article-title":"Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients","volume":"82","author":"Menon","year":"2002","journal-title":"Lab. Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cas.12842","article-title":"Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3\/ITGB1 signaling in prostate cancer","volume":"107","author":"Kurozumi","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/pro.2741","article-title":"A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target","volume":"24","author":"Lee","year":"2015","journal-title":"Protein Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1096\/fj.03-1110fje","article-title":"Tenascin-C and SF\/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac","volume":"18","author":"Nguyen","year":"2004","journal-title":"FASEB J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1007\/s13277-014-1923-z","article-title":"Clinical significance of serum tenascin-c levels in epithelial ovarian cancer","volume":"35","author":"Didem","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Waalkes, S., Atschekzei, F., Kramer, M.W., Hennenlotter, J., Vetter, G., Becker, J.U., Stenzl, A., Merseburger, A.S., Schrader, A.J., and Kuczyk, M.A. (2010). Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-503"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1535-6108(03)00058-8","article-title":"Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells","volume":"3","author":"Weeraratna","year":"2003","journal-title":"Cancer Cell."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.18632\/oncotarget.3118","article-title":"Fibrillin -1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/bjc.1996.626","article-title":"Epithelial ovarian cancer: Influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression","volume":"74","author":"Sarhanis","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/85.14.1159","article-title":"Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer","volume":"85","author":"Bell","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1055-9965.EPI-08-0399","article-title":"Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer","volume":"17","author":"Gates","year":"2008","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-10-2711","article-title":"Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF","volume":"71","author":"Lai","year":"2011","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1158\/0008-5472.CAN-06-4567","article-title":"Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer","volume":"67","author":"Kikuchi","year":"2007","journal-title":"Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1074\/jbc.273.12.7123","article-title":"GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells","volume":"273","author":"Fridell","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000079499","article-title":"Coexpression of Gas6\/Axl in human ovarian cancers","volume":"66","author":"Sun","year":"2004","journal-title":"Oncology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1158\/1078-0432.CCR-10-2774","article-title":"Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Gambaro, K., Quinn, M.C., C\u00e1ceres-Gorriti, K.Y., Shapiro, R.S., Provencher, D., Rahimi, K., Mes-Masson, A.M., and Tonin, P.N. (2015). Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1138-8"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.1074\/jbc.M114.571620","article-title":"Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis","volume":"289","author":"Soki","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Tibaldi, L., Leyman, S., Nicolas, A., Notebaert, S., Dewulf, M., Ngo, T.H., Zuany-Amorim, C., Amzallag, N., Bernard-Pierrot, I., and Sastre-Garau, X. (2013). New blocking antibodies impede adhesion, migration and survival of ovarian cancer cells, highlighting MFGE8 as a potential therapeutic target of human ovarian carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072708"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"E1334","DOI":"10.1210\/jc.2013-1053","article-title":"Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer","volume":"98","author":"Guan","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1245\/s10434-009-0533-2","article-title":"Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: A Hospital-based Cohort Study in Iowa","volume":"16","author":"Lal","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00701-005-0515-5","article-title":"Rac2 expression and mutation in human brain tumors","volume":"147","author":"Hwang","year":"2005","journal-title":"Acta Neurochir."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.0702176104","article-title":"An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone","volume":"104","author":"Bey","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2004.03.027","article-title":"Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer","volume":"93","author":"Olson","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1159\/000487348","article-title":"Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells","volume":"45","author":"Cai","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/jid.2015.160","article-title":"Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma","volume":"135","author":"Hwang","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6605570","article-title":"miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer","volume":"102","author":"Chiyomaru","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_120","first-page":"371","article-title":"Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancer","volume":"33","author":"Hanker","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"712438","DOI":"10.1155\/2015\/712438","article-title":"Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival","volume":"2015","author":"Karapetsas","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2010.10.027","article-title":"Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells","volume":"301","author":"Satelli","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s13058-014-0486-7","article-title":"E2F4 regulatory program predicts patient survival prognosis in breast cancer","volume":"16","author":"Khaleel","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/8.4.607","article-title":"Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer","volume":"8","author":"Richards","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/bcr2832","article-title":"Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals","volume":"13","author":"Kuusisto","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2010.08.020","article-title":"Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer","volume":"72","author":"Kikuchi","year":"2011","journal-title":"Lung Cancer"},{"key":"ref_127","first-page":"5959","article-title":"resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation","volume":"60","author":"Sagara","year":"2000","journal-title":"Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/gcc.2870080212","article-title":"Mapping of the 19p13 breakpoint in an ovarian carcinoma between the INSR and TCF3 loci","volume":"8","author":"Aman","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_129","first-page":"315","article-title":"Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme","volume":"9","author":"Hou","year":"2016","journal-title":"Onco Targets Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-06-2366","article-title":"Amplification of MDS1\/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer","volume":"67","author":"Nanjundan","year":"2007","journal-title":"Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neo.2014.08.011","article-title":"Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation","volume":"16","author":"Grasso","year":"2014","journal-title":"Neoplasia"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.humpath.2011.06.003","article-title":"SCARA3 mRNA is over expressed in ovarian carcinoma compared with breast carcinoma effusions","volume":"43","author":"Bock","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-006-9315-8","article-title":"Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer","volume":"102","author":"Kulkarni","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ygyno.2007.11.019","article-title":"The prognostic significance of elongation factor eEF1A2 in ovarian cancer","volume":"108","author":"Pinke","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1126\/science.1066326","article-title":"KLF6, a candidate tumor suppressor gene mutated in prostate cancer","volume":"294","author":"Narla","year":"2001","journal-title":"Science"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1158\/1078-0432.CCR-06-0054","article-title":"Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination","volume":"12","author":"DiFeo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2013.11.008","article-title":"The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors","volume":"8","author":"Quigley","year":"2014","journal-title":"Mol. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/9\/2\/39\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:43:57Z","timestamp":1760186637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/9\/2\/39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":137,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["diagnostics9020039"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics9020039","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]}}}